Equities

Plantarc Bio Ltd

PLNT:TLV

Plantarc Bio Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (ILa)270.00
  • Today's Change0.00 / 0.00%
  • Shares traded37.99k
  • 1 Year change-63.33%
  • Beta0.1763
Data delayed at least 20 minutes, as of May 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Plantarc Bio Ltd is an Israel-based research and development company. Plantarc Bio Ltd operates as agricultural biotechnology (Ag-Bio) company and develops Direct-In-Plant (DIP) discovery platform which enables to discover and develop genes that has positive effects on plants, such as yield improvement, drought resistance and herbicide and insects tolerance. Company's platform allows scanning of millions of genes, at once and at scale, directly on plants, so it makes gene discovery more effective and efficient. Moreover the Company is engaged in in the development of RNAi based external applications for crop protection and yield enhancement and develops Cannabis Gene-Based Innovation and is focused on activities: production of active molecules (such as CBD/THC) in a bioreactor in large scale, and gene-editing in Cannabis to develop improved strains.

  • Revenue in ILS (TTM)4.78m
  • Net income in ILS-2.11m
  • Incorporated2014
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Univo Pharmaceuticals Ltd52.65m-32.19m3.06m12.00--0.1744--0.0582-10,833.61-10,833.6118,078.285,333.010.64062.1520.71---39.71-40.93-58.86-53.8628.88---61.99-95.670.6479-4.900.6719--25.38170.24-3,522.40--428.61--
Pharmocann Global Ltd14.41m-9.73m5.14m47.00--5.88--0.3564-5.34-5.347.320.34161.143.516.93---77.32-60.73-170.19-74.16-9.5123.70-67.54-84.620.704-82.200.3394---36.38-0.493561.46---51.49--
HBL Hadasit Bio Holdings Ltd0.00-29.19m6.04m16.00--1.02-----2.63-2.630.000.53540.00-------124.15-13.00-137.60-13.91-------100,517.40---0.0650.2098------6.48------
Plantarc Bio Ltd4.78m-2.11m8.57m----0.7166--1.79-0.6359-0.63591.443.610.3363--13.48---14.84-37.73-16.44-41.7761.43---44.12-376.62----0.0059------57.69--111.75--
Flying Spark Ltd16.00k-11.47m9.53m--------595.86-1.84-1.840.0022-------------------218.75---71,731.25-----41.04----71.43---248.13------
Millennium Food-Tech LP464.00k-25.91m19.26m2.00--0.1713--41.51-0.9204-0.92040.0183.440.0038--3.40232,000.00-21.38---21.52-------5,584.27-----0.170.00--224.48---84.01------
Kadimastem Ltd0.00-12.01m20.50m32.00---------1.22-1.220.00-1.040.00-------115.17-155.33-1,153.60-1,831.12-----------9.443.22------47.14---50.73--
Nextage Therapeutics Ltd876.00k-4.07m22.69m--------25.90-0.1396-0.13960.03-0.09580.672--6.82---322.44-188.94---423.7625.6833.33-479.79-2,486.19---18.46------17.9927.21------
Tikun Olam Cannbit Pharmaceuticals Ltd44.23m-88.89m31.01m51.00--0.7226--0.7012-1.43-1.430.70180.50510.3792.8719.85867,215.70-80.56-30.17-99.81-35.04-0.4273---212.57-146.420.5033-30.020.3778---10.28---84.28---8.71--
Can Fite Biopharma Ltd2.74m-28.20m39.18m5.00--1.54--14.28-0.0224-0.02240.00220.0170.0771----548,883.80-79.22-102.29-103.51-131.07-----1,027.46-1,105.36----0.00---8.27-27.9224.96---42.92--
Wilk Technologies Ltd0.00-10.93m42.46m4.00--6.14-----0.1807-0.18070.000.10060.00-------80.10-266.55-96.15-298.65-------97,340.88---39.620.4049------36.02------
Data as of May 15 2024. Currency figures normalised to Plantarc Bio Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

3.90%Per cent of shares held by top holders
HolderShares% Held
Yelin Lapidot Mutual Fund Management Ltd.as of 29 Feb 2024129.28k3.90%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.